Ryan D. Maynard
2010
In 2010, Ryan D. Maynard earned a total compensation of $1.7M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 49% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $1,198,916 |
| Salary | $383,577 |
| Other | $540 |
| Total | $1,743,033 |
Maynard received $1.2M in option awards, accounting for 69% of the total pay in 2010.
Maynard also received $160K in non-equity incentive plan, $383.6K in salary and $540 in other compensation.
Rankings
In 2010, Ryan D. Maynard's compensation ranked 3,483rd out of 10,439 executives tracked by ExecPay. In other words, Maynard earned more than 66.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,483 out of 10,439 | 67th |
Division Manufacturing | 1,211 out of 3,838 | 68th |
Major group Chemicals And Allied Products | 237 out of 926 | 74th |
Industry group Drugs | 131 out of 685 | 81st |
Industry Pharmaceutical Preparations | 99 out of 481 | 79th |
Source: SEC filing on April 3, 2013.
Maynard's colleagues
We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2010.
2010
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2010
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2010
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2010
Elliott Grossbard
Rigel Pharmaceuticals